1,375 reports of this reaction
2.7% of all AMOXICILLIN AND CLAVULANATE POTASSIUM reports
#4 most reported adverse reaction
PYREXIA is the #4 most commonly reported adverse reaction for AMOXICILLIN AND CLAVULANATE POTASSIUM, manufactured by Allegis Holdings, LLC. There are 1,375 FDA adverse event reports linking AMOXICILLIN AND CLAVULANATE POTASSIUM to PYREXIA. This represents approximately 2.7% of all 50,339 adverse event reports for this drug.
Patients taking AMOXICILLIN AND CLAVULANATE POTASSIUM who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PYREXIA is a less commonly reported adverse event for AMOXICILLIN AND CLAVULANATE POTASSIUM, but still significant enough to appear in the safety profile.
In addition to pyrexia, the following adverse reactions have been reported for AMOXICILLIN AND CLAVULANATE POTASSIUM:
The following drugs have also been linked to pyrexia in FDA adverse event reports:
PYREXIA has been reported as an adverse event in 1,375 FDA reports for AMOXICILLIN AND CLAVULANATE POTASSIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
PYREXIA accounts for approximately 2.7% of all adverse event reports for AMOXICILLIN AND CLAVULANATE POTASSIUM, making it a notable side effect.
If you experience pyrexia while taking AMOXICILLIN AND CLAVULANATE POTASSIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.